In vitro elution of antibiotic from antibiotic-impregnated biodegradable calcium alginate wound dressing

Journal of Trauma - Injury, Infection and Critical Care

Volumn 47, Issue 1, 1999, Pages 136-141

  Lin, Song Shu ^b   Ueng, Steve W N ^b   Lee, Shiuann Sheng ^a   Chan, Err Cheng ^b   Chen, Kuei Tian ^b   Yang, Chuen Yung ^b   Chen, Chao Yu ^b   Chan, Yi Sheng ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM ALGINATE; VANCOMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; BIODEGRADATION; COLORIMETRY; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG MIXTURE; FIBROBLAST; FREEZE DRYING; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SURGICAL INFECTION; WOUND DRESSING;

EID: 0032771633     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/00005373-199907000-00027     Document Type: Article

References (44)

1. Barrett SE, Varley SJ. The effects of calcium alginate on wound healing. Ann R Coll Surg Engl. 1987;69:153-155.
2. Gensheimer D. A review of calcium alginates. Ostomy Wound Manage. 1993;39:34-38,42-43.
3. Suzuki Y, Nishimura Y, Tanihara M, et al. Evaluation of a novel alginate gel dressing: cytotoxicity to fibroblasts in vitro and foreign-body reaction in pig skin in vivo. J Biomed Mater Res. 1998;39:317-322.
4. Agren MS. Four alginate dressings in the treatment of partial thickness wounds: a comparative experimental study Br J Plastic Surg. 1996;49:129-134.
5. Lim TC, Tan WT. Treatment of donor site detects [letter]. Br J Plast Surg. 1992;45:488.
6. Porter JM. A comparative investigation of reepithelialisation of split skin graft donor areas after application of hydrocolloid and alginate dressings. Br J Plast Surg. 1991;44:333-337.
7. Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III open fracture. J Trauma. 1984; 24:742-746.
8. Cierny G III, Mader JT. A clinical staging system for adult osteomyelitis. Contemp Orthop. 1985;10:17-37.
9. Ueng WN, Hsueh S, Shin CH. Hematogenous osteomyelitis with inflammatory cyst formation mimicking a soft tissue tumor. Clin Orthop. 1994;302:231-234.
10. Couch L, Cierny G, Mader JT. Inpatient and outpatient use of the Hickman catheter for adults with osteomyelitis. Clin Orthop. 1987;219:226-235.
11. Henry SL, Seligson D, Mangino P, et al. Antibiotic-impregnated beads, Part I: Bead implantation versus systemic therapy. Orthop Rev. 1991;20:242-247.
12. Kitchell J, Wise D. Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems. Methods Enzymol. 1985; 112:436-448.
13. Ueng SWN, Wei FC, Lee SS, Shin CH. Management of large infected tibial defect with antibiotic beads local therapy and staged fibular osteoseptocutaneous free transfer. J Trauma. 1997;43:268-274.
14. Buchholz HW, Engelbrecht H. Uber die depotwirkung einiger antibiotica bei vermischung mit dem kunstharz palacos. Chirurg. 1970;11:511-515.
15. Calhoun JH, Mader JT. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin Orthop. 1997; 341:207-214.
16. Majid SA, Lindberg LT, Gunterberg B, et al. Gentamicin-PMMA beads in the treatment of chronic osteomyelitis. Acta Orthop Scand. 1985;56:265-268.
17. Mader JT, Calhoun J, Cobos J. In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads. Antimicrob Agents Chemother. 1997;41:415-418.
18. Setterstrom JA, Tice TR, Myers WE. Development of encapsulate antibiotics for topical administration to wounds. In: Kim SW, (ed). Recent Advances in Drug Delivery Systems. New York: Plenum, 1984:185-198.
19. Attwood AI. Calcium alginate dressing accelerate split skin graft donor site healing. Br J Plast Surg. 1989;42:373-379.
20. Lawrence IG, Lear JT, Burden AC. Alginate dressings and the diabetic foot ulcer. Pract Diabetes Int. 1997;14:61-62.
21. Groces AR, Lawrence JC. Alginate dressing as a donor site haemostat. Ann R Coll Surg Engl. 1986;68:27.
22. Jarvis PM, Galvin DAJ, Blair SD, McCollum CN. How does calcium alginate hemostasis in surgery? XIth International congress of Thrombosis and Hemostasis, Brussels, 1987:8-10.
23. Downs EC, Robertson NE, Riss TL, Plunkett ML. Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro. J Cell Physiol. 1992;152:422-429.
24. Lansdown AB, Payne MJ. An evaluation of the local reaction and biodegradation of calcium sodium alginate (Kaltostat) following subcutaneous implantation in the rat. J R Coll Surg Edinb. 1994;39:284-288.
25. Chin K, Shimizu K, Shoji T. An experimental study on a chemosensitivity test with alginate microcapsule. Feasibility of in vivo succinic dehydrogenase inhibition test. J Nippon Med Sch. 1994;61:422-434.
26. Christopher MH, Vender JR, Black P. Chemotherapy in experimental brain tumor, part I: In vitro colorimetric MTT assay. J Neuro-Oncol. 1998;36:1-6.
27. Ferrari M, Fornasiero MC, Isetta AM. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J Immunol Methods. 1990;131:165-172.
28. Heald KA, Jay TR, Downing R. Assessment of the reproducibility of alginate encapsulation of pancreatic islets using the MTT colorimetric assay. Cell Transplant. 1994; 3:333-337.
29. O'Sullivan DG, Sherman IW, Phillips DE. The role of calcium alginate swabs in adenotonsillectomy. Clin Otolaryngol. 1992;17:403-405.
30. Hkapelle M, Ridder St, Elisabeth Z. Analysis of Vancomycin in Serum. Chrompack Application note 400-HPLC Application Book. Chrompack Inter BV Publication, 1996:430.
31. Khalfi F, Deni T, Gressier B, et al. Compatibility and stability of vancomycin hydrochloride with PVC infusion material in various conditions using stability-indicating high-performance liquid chromatographic assay. Int J Pharm (Amst). 1996;139:243-247.
32. Zhang X, Wyss UP, Pichora D, et al. Controlled release of albumin from biodegradable poly(DL-lactide) cylinders. J Controlled Release. 1993;25:61-69.
33. Zhang X, Wyss UP, Pichora D, et al. Biodegradable controlled antibiotic release devices for osteomyelitis: Optimization of release properties. J Pharm Pharmacol. 1994;46:718-724.
34. Matthew IR, Browne RM, Frame JW, Millar BG. Subperiosteal behavior of alginate and cellulose wound dressing materials. Biomaterials. 1995;16:265-274.
35. Sirimanna KS, Todd GB, Madden GJ. A randomized study to compare calcium sodium alginate fiber with two commonly used materials for packing after nasal surgery. Clin Otolaryngol. 1992;17:237-239.
36. Esquisabel A, Hernandez RM, Igartua M, et al. Production of BCG alginate-PLL microcapsules by emulsification/internal gelation. J Microencapsul. 1997; 14:627-638.
37. Guyton AC, Hall JE. Functional organization of the human body and control of the internal environment. In: Guyton AC, ed. Textbook of Medical Physiology, 9th ed. Philadelphia: WB Saunders Company, 1996.
38. Kirkpatrick DK, Trachtenberg LS, Mangino PD, et al. In vitro characteristics of tobramycin-polymethylmethacrylate beads: Compressive strength and leaching. Orthopedics. 1985;8:1130-1133.
39. Kobayshi H, Shirake K, Ikada Y. Toxicity test of biodegradable polymer by implantation in rabbit cornea. J Biomed Mater Res. 1992;26:1463-1476.
40. Paham GJ, Mangino P, Seligson D, et al. Antibiotic-impregnated beads, Part II: Factors in antibiotics. Orthop Rev. 1991;20:331-337.
41. Lawson KJ, Marks KE, Brems J, et al. Vancomycin vs. Tobramycin elution from polymethylmethacrylate: an in vitro study. Orthopedics. 1990;13:521-524.
42. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
43. Matthew IR, Browne RM, Frame JW, Millar BG. Tissue response to a haemostatic alginate wound dressing in tooth extraction sockets. Br J Oral Maxillofac Surg. 1993;31:165-169.
44. Odell EW, Oades P, Lombardi T. Symptomatic foreign body reaction to haemostatic alginate. Br J Oral Maxillofac Surg. 1994;32:178-179.